* No interrumpir el tratamiento sin consultar: Los pacientes no deben interrumpir el tratamiento con GLP-1 RA por su cuenta
Managing Side Effects Through Timing Side effects usually occur as your body adjusts to a new dosage level
PE: Are there alternative weight-loss medications compounding pharmacies can turn to instead of semaglutide
You should contact your GP or healthcare provider if: Night sweats are severe, persistent, or worsening over time You experience unintentional weight loss beyond what is expected from Mounjaro therapy Night sweats are accompanied by fever, chills, or signs of infection You notice fatigue, weakness, or unexplained changes in appetite There are symptoms suggestive of hypoglycaemia , such as confusion, tremor, palpitations, or waking feeling unwell You develop new or unusual symptoms such as lumps, persistent cough, or changes in bowel habits You experience severe, persistent abdominal pain radiating to the back (seek urgent medical attention as this could indicate pancreatitis) These features may indicate underlying conditions that require investigation, such as infections (including tuberculosis), hyperthyroidism, lymphoma, or other systemic illnesses
The fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg pairs a GLP-1 receptor agonist with a long-acting analogue of amylin, a pancreatic hormone that reduces appetite and slows gastric emptying
And if you get a positive pregnancy test by surprise, take a deep breath and call your ob-gyn
